Where Infusion Demand Is Growing Fastest
Medicare Part B spending on infusion drugs given in doctors' offices and clinics keeps climbing. The table below ranks states by Medicare infusion drug dollars per registered infusion clinic, a rough measure of how much demand each clinic serves.
StateMedicare infusion drugsClinicsPer clinic
Iowa$86.2M (+27%)8$10.8M
Nebraska$82.8M (+18%)8$10.4M
Arkansas$131M (+15%)15$8.8M
Kansas$118M (+38%)15$7.9M
Pennsylvania$251M (+32%)33$7.6M
Illinois$256M (+14%)39$6.6M
Virginia$255M (+11%)42$6.1M
South Carolina$191M (+18%)32$6.0M
Maryland$237M (+23%)40$5.9M
Wisconsin$63.2M (+113%)11$5.7M
Tennessee$197M (+20%)36$5.5M
Indiana$79.7M (-10%)15$5.3M
Minnesota$86.6M (+27%)17$5.1M
New York$228M (+10%)53$4.3M
North Carolina$157M (-2%)39$4.0M
California$542M (+33%)139$3.9M
New Jersey$172M (+17%)45$3.8M
Alabama$141M (+12%)37$3.8M
Missouri$102M (-12%)27$3.8M
Oklahoma$80.6M (+23%)22$3.7M
Mississippi$74.2M (+17%)21$3.5M
Florida$749M (+18%)239$3.1M
Arizona$221M (+24%)71$3.1M
Ohio$130M (+22%)47$2.8M
Texas$504M (+26%)240$2.1M
Georgia$143M (+23%)69$2.1M
Nevada$72.6M (+19%)37$2.0M
Washington$54.9M (+0%)34$1.6M
Michigan$75.0M (+5%)47$1.6M
Colorado$101M (+25%)87$1.2M
This is a signal, not a census. Many infusions happen in hospital outpatient departments and oncology practices that never register as an infusion clinic, and Medicare is only part of the market. But states near the top are where patients are most likely to drive far for care, and where a new clinic has room to grow.